Tepoxalin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11466 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 36 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | osteoarthritis | KG + DL |
| 2 | osteoarthritis susceptibility | KG + DL |
| 3 | rheumatoid arthritis | KG + DL |
| 4 | gout | KG + DL |
| 5 | hemoglobinopathy | KG + DL |
| 6 | pseudoachondroplasia | KG + DL |
| 7 | brachyolmia | KG + DL |
| 8 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 9 | beta-thalassemia with other manifestations | KG + DL |
| 10 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 11 | myosclerosis | KG + DL |
| 12 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 13 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 14 | pyruvate kinase deficiency of red cells | KG + DL |
| 15 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 16 | pyropoikilocytosis, hereditary | KG + DL |
| 17 | arthropathy | KG + DL |
| 18 | brachydactyly-syndactyly syndrome | KG + DL |
| 19 | myocardial infarction | KG + DL |
| 20 | female breast carcinoma | KG + DL |
| 21 | congestive heart failure | KG + DL |
| 22 | headache disorder | KG + DL |
| 23 | trigeminal autonomic cephalalgia | KG + DL |
| 24 | posteroinferior myocardial infarction | KG + DL |
| 25 | posterolateral myocardial infarction | KG + DL |
| 26 | acute pulmonary heart disease | KG + DL |
| 27 | septal myocardial infarction | KG + DL |
| 28 | high output heart failure | KG + DL |
| 29 | idiopathic granulomatous myositis | KG + DL |
| 30 | myositis fibrosa | KG + DL |
| 31 | coronary stenosis | KG + DL |
| 32 | tendinitis | KG + DL |
| 33 | hepatic porphyria | KG + DL |
| 34 | symptomatic heart failure | KG + DL |
| 35 | Jeune syndrome situs inversus | KG + DL |
| 36 | paratenonitis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.